January 11-14, 2027 | San Francisco
2027 Participating Companies
JW Therapeutics (HKEX: 2126) is an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing CAR-T/ cell immunotherapy products. We are open to collaborations in CAR-T, cell therapy and beyond.